MLICM
STXS icon

Metropolitan Life Insurance Company (MetLife)’s Stereotaxis STXS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,356
Closed -$33.2K – 2650
2021
Q4 		$33.2K Sell
5,356
-295
-5% -$1.76K ﹤0.01% 2731
2021
Q3 		$30.4K Sell
5,651
-8,593
-60% -$64.8K ﹤0.01% 2805
2021
Q2 		$137K Buy
+14,244
New +$112K ﹤0.01% 2417
2020
Q3 		– Sell
-15,729
Closed -$70.2K – 2591
2020
Q2 		$70.2K Buy
+15,729
New +$63.6K ﹤0.01% 2436

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $190M AUM 51.6% 1-Year Est. Return
ITP
Iron Triangle Partners Cos Cob, Connecticut $875M AUM 49.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s STXS Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Stereotaxis (STXS) in Q1 2022, closing a stake of 5,356 shares — an estimated $33.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in STXS in Q2 2020 and held it in 4 quarters. The position peaked at $137K in Q2 2021. 93 funds tracked by Wall St. Rank hold STXS as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Stereotaxis position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,356 Stereotaxis shares in Q1 2022, an estimated $33.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Stereotaxis in Q2 2020 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Stereotaxis position peaked at $137K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.